Canaccord analyst Richard Close lowered the firm’s price target on Progyny (PGNY) to $17 from $18 and keeps a Hold rating on the shares. The firm lowered its estimates after another quarter falling short of expectations and lowering of guidance.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter